Benitec Biopharma appoints interim CEO

Company News

Benitec Biopharma Limited (ASX:BLT) has announced that Dr Peter French will step down as Managing Director and CEO of the company. 
 
Mr Greg West, Benitec’s Chief Financial Officer and Company Secretary has been appointed as the interim CEO. 
 
The company says it has commenced a global search for a new CEO and its intended the new CEO will be based in the United States. 
 
This is in line with Benitec’s goal to establish a stronger team in the US following its Nasdaq listing in August.
 
Benitec Biopharma reported a net loss of $11.5 million at 30 June 2015.